Presentation
13 March 2024 Fiberoptic Raman endoscopy enables intraoperative, real-time, in vivo bladder cancer diagnosis
Author Affiliations +
Abstract
We report on the development of a simultaneous fingerprint and high-wavenumber (FP/HW) Raman endoscopy platform for real-time, in vivo diagnosis of bladder cancer during transurethral resection of bladder tumor (TURBT). Significant tissue Raman spectral differences are observed in both FP (i.e., 800 – 1800 cm-1) and HW (i.e., 2800 – 3600 cm-1) regions between normal and cancer as well as between normal and carcinoma in situ (CIS) tissue sites, indicating the biomolecular differences among cancer, CIS and normal tissue sites. A cancer diagnosis model has been developed based on partial-least-squares linear-discriminant-analysis (PLS-LDA) with leave-one-tissue site-out cross-validation (LOOCV). The diagnosis model yields the diagnostic accuracy of > 90 % for identifying both cancer and CIS sites from normal bladder tissue. Through this work, we demonstrate that in vivo FP/HW fiberoptic Raman endoscopy is a promising and effective clinical tool for rapid diagnosis of cancer and pre-cancer tissue sites during TURBT from biomolecular level.
Conference Presentation
© (2024) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Chi Shu, Carmen Ka Man Yu, Chang Liu, Bocheng Qiu, Zhiwei Huang, Arshvin Kesavan, and Edmund Chiong "Fiberoptic Raman endoscopy enables intraoperative, real-time, in vivo bladder cancer diagnosis", Proc. SPIE PC12839, Biomedical Vibrational Spectroscopy 2024: Advances in Research and Industry, PC128390A (13 March 2024); https://doi.org/10.1117/12.3008510
Advertisement
Advertisement
KEYWORDS
Raman spectroscopy

Bladder cancer

Endoscopy

Cancer

Fiber optics

Tissues

Biomolecules

Back to Top